Wholesale of pharmaceutical and medical goods
BIO PHARMA NORWAY AS
Revenue 2024
NOK 1.9m
Operating profit
NOK −38,000
Equity
NOK 1.7m
Incorporated
2003
Share capital
NOK 136,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 1.9m | |
| Total operating costs | 2.0m | |
| Operating profit (EBIT) | −38k | |
| Net financial items | −24k | |
| Profit for the year | −61k |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 3.8m | |
| of which current assets | 3.3m | |
| Equity | 1.7m | |
| Total liabilities | 2.1m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.